Ustekinumab in the therapy of chronic plaque psoriasis
Jenna L O’Neill, Robert E KalbState University of New York at Buffalo, School of Medicine and Biomedical Sciences, Department of Dermatology, NY, USAAbstract: Psoriasis is a chronic inflammatory disorder characterized by T cell dysregulation and a chronic inflammatory infiltrate within...
Guardado en:
Autores principales: | Jenna L O’Neill, Robert E Kalb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4b41c48fa8894b93843f32c8ef6c87df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Potential role of ustekinumab in the treatment of chronic plaque psoriasis
por: Santo Raffaele Mercuri, et al.
Publicado: (2010) -
Infliximab for the treatment of plaque psoriasis
por: Jennifer S Gall, et al.
Publicado: (2008) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
por: Matsumoto S, et al.
Publicado: (2018) -
Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
por: Hampton P, et al.
Publicado: (2021) -
Biological drugs targeting the immune response in the therapy of psoriasis
por: Saveria Pastore, et al.
Publicado: (2008)